Empowering brand success with proven acquisition and adherence solutions

One of the biggest challenges facing the pharmaceutical industry today is medication non-adherence. Non-adherence is not only detrimental to patient health, but also to the health of your brand.

In the United States, adherence rates for chronic medications average only 50%, with one-third of all prescribed medications going unfilled. This lack of adherence not only accounts for 125,000 deaths annually in the U.S., but also costs the global Pharmaceutical Industry an estimated $30 Billion per year.1

McKesson Patient Relationship Solutions is a unique division of McKesson Corporation, one of the world's leading healthcare companies, focused exclusively on helping pharmaceutical and device manufacturers reach patients to drive acquisition and adherence for their brands.

With more than 18 years of experience providing winning consumer relationship programs, extensive industry relationships and a complete portfolio of resources to support your acquisition and adherence programs, we are committed to improving patient outcomes while optimizing brand performance.


Leveraging our experience developing successful programs, we can design a custom solution using our in-market adherence programs or build a completely new solution to meet your brand objectives. Our solutions are so successful that in the last year alone our programs have been utilized by more than 1 million patients.


1Ensuring Profitable Patient Adherence Programs: Using Analytics to Release the Hidden Value in Brands. Eularis , June 2011